Baxter Launches At-Risk Generic During Appeal
Baxter Healthcare Corp. has ignored an appeal by rival Abbott Laboratories to launch at risk a generic version of Abbot's popular inhaled anesthetic Ultane in the United States, Europe and Japan...To view the full article, register now.
Already a subscriber? Click here to view full article